CAROLINA RAUDEZ: Open Payments
NPI 1598202517 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,275 in 40 payments from 13 companies in 2025. Trend: 2023 $420 · 2024 $993 · 2025 $1,275
Food & beverage: $1,275
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $363 |
| Novartis Pharmaceuticals Corporation | 4 | $199 |
| Novo Nordisk Inc | 5 | $168 |
| Exact Sciences Corporation | 8 | $168 |
| Lilly USA, LLC | 2 | $104 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| Verity Pharmaceuticals Inc. | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $35 |
| Gilead Sciences, Inc. | 1 | $35 |
| Astellas Pharma US Inc | 1 | $34 |
Products named: LEQVIO, AIRSUPRA, The Cologuard Plus Collection Kit, Ozempic, BREZTRI, JARDIANCE, Tlando, Wegovy.
Industry payments across FL — which companies pay providers there.
